Caspian Journal of Internal Medicine
Babol University of Medical Sciences
Tue, Mar 18, 2025
[Archive]
Volume 12 - Case Supplement
Caspian J Intern Med 2021, 12 - Case Supplement : 447-450 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Eghbali F, Karami R. Refractory hypoglycemia induced by a duodenal wall gastrointestinal stromal tumor: A case report. Caspian J Intern Med 2021; 12 (S2) :447-450
URL: http://caspjim.com/article-1-2227-en.html
URL: http://caspjim.com/article-1-2227-en.html
Minimally Invasive Surgery Research Center, Iran University of Medical Sciences, Tehran, Iran , reza_karami1367@yahoo.com
Abstract: (2432 Views)
Background: Tumor-associated hypoglycemia can be caused by non-islet cell tumors including gastrointestinal stromal tumor (GIST) which is a rare paraneoplastic syndrome that leads to the release of insulin-like growth factor-2 (IGF-2).
Case Presentation: We report the case of a 45-year old woman who was admitted to our hospital with refractory hypoglycemic episodes. We found normal serum insulin and c-peptide level and abdominal CT-scan showed a small duodenal wall lesion suggesting insulinoma. After tumor resection, hypoglycemia symptoms were recovered, but the pathological findings demonstrated the lesion was GIST.
Conclusion: In a small gastrointestinal lesion with hypoglycemic symptoms we should consider IGF-II secreting GIST in addition to insulinoma.
Case Presentation: We report the case of a 45-year old woman who was admitted to our hospital with refractory hypoglycemic episodes. We found normal serum insulin and c-peptide level and abdominal CT-scan showed a small duodenal wall lesion suggesting insulinoma. After tumor resection, hypoglycemia symptoms were recovered, but the pathological findings demonstrated the lesion was GIST.
Conclusion: In a small gastrointestinal lesion with hypoglycemic symptoms we should consider IGF-II secreting GIST in addition to insulinoma.
Type of Study: case report |
Subject:
Surgery
Received: 2020/02/22 | Accepted: 2020/08/1 | Published: 2021/07/24
Received: 2020/02/22 | Accepted: 2020/08/1 | Published: 2021/07/24
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
